Related Experiment Videos
The role of partial liver resection for metastatic cancer
1Memorial Sloan-Kettering Cancer Center.
Oncology (Williston Park, N.Y.)
|March 1, 1987
Abstract:
Major progress has been made during the last decade in the safety and results of partial liver resection for metastatic cancer. Survival rates of 20% to more than 40% for five or more years can now be achieved.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1993
Hypophosphatemia after major hepatic resection.
Surgery·1992
Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma.
Archives of surgery (Chicago, Ill. : 1960)·1991
Brachytherapy and function-saving resection of soft tissue sarcoma arising in the limb.
International journal of radiation oncology, biology, physics·1991
The role of multimodality therapy in soft-tissue sarcoma.
Annals of surgery·1991
Role of brachytherapy in recurrent extremity sarcoma in patients treated with prior surgery and irradiation.
International journal of radiation oncology, biology, physics·1991
Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.
Oncology (Williston Park, N.Y.)·2026
Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.
Oncology (Williston Park, N.Y.)·2026
Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.
Oncology (Williston Park, N.Y.)·2026
Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.
Oncology (Williston Park, N.Y.)·2026
Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.
Oncology (Williston Park, N.Y.)·2026
Collagen-Binding IL-15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self-Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immunity.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Breaking the Lipid Bottleneck: A Mitophagy-Driven Nanoregulator Amplifies Ferroptosis for Colorectal Cancer Immunotherapy.
Small (Weinheim an der Bergstrasse, Germany)·2026
Metastasis-directed local therapy and strategic de-escalation of systemic therapy for oligometastatic esophageal squamous cell carcinoma.
Japanese journal of clinical oncology·2026